Lassa Fever Confirmed in Death of U.S. Traveler Returning from Liberia

Atlanta: The CDC and the New Jersey Department of Health have confirmed a death from Lassa fever which was diagnosed earlier today in a person returning to the United States from Liberia. The patient traveled from Liberia to Morocco to JFK International Airport on May 17th. The patient did not have a fever on departure from Liberia, did not report symptoms such as diarrhea, vomiting, or bleeding during the flight, and his temperature was taken on arrival in the U.S. and he did not have a fever at that time. On May 18th, the patient went to a hospital in New Jersey with symptoms of a sore throat, fever and tiredness.

Lassa fever controls need to consider human to human transmission and the role of ‘super spreaders’, say researchers

University of Cambridge. UK: One in five cases of Lassa fever – a disease that kills around 5,000 people a year in West Africa – could be due to human-to-human transmission, with a large proportion of these cases caused by ‘super-spreaders’, according to research published today in the journal PLOS Neglected Tropical Diseases.

Lassa fever

CDC. US: Lassa fever is an acute viral illness that occurs in west Africa. The illness was discovered in 1969 when two missionary nurses died in Nigeria. The virus is named after the town in Nigeria where the first cases occurred. The virus, a member of the virus family Arenaviridae, is a single-stranded RNA virus and is zoonotic, or animal-borne.
Lassa fever is endemic in parts of west Africa including Sierra Leone, Liberia, Guinea and Nigeria; however, other neighboring countries are also at risk, as the animal vector for Lassa virus, the "multimammate rat" (Mastomys natalensis) is distributed throughout the region.